Our office will be closed Thursday and Friday, November 26th and 27th for the Thanksgiving holiday. We will reopen at regular business hours on Monday, November 30th.
Variability in Measuring Physical Activity in Children with Cerebral Palsy.
- Published on May 12, 2014
Introduction: To establish the variability in the measurement of habitual physical activity (HPA) using the ActiGraph(R) GT3X+ accelerometer in children with cerebral palsy (CP).
Method: Repeated measures: Independently ambulant children with unilateral CP (n=30; aged 11y3m [2y4m]) completed standardized tasks over two consecutive days wearing an ActiGraph(R)GT3X+ accelerometer and heart rate monitor. Testing protocol comprised five minutes of seated rest (REST), walking at light (LW), moderate (MW) and vigorous (VW) pace, and rapid stepping on/off a step (STEP). Agreement was calculated between days using intra-class correlation coefficients (ICC; two-factor mixed agreement model). Minimum detectable difference was calculated (MDD=[SD[square root]1-ICC]x1.96x[square root]2). Performance variability: Participants (n=102) wore an ActiGraph(R)GT3X+ accelerometer for four days in the community. Activity counts were converted into activity intensity using uni-axial derived cut points to classify the time spent in moderate-to-vigorous physical activity (MVPA). Between-day intra-class reliability coefficients (R) and Spearman-Brown prophecy formula (ICCdesired/[1-ICCdesired])([1-ICCestimated]/ICCestimated) were calculated.
Results: Agreement between repeated measures was strong for light and MVPA (ICC=0.80). For MVPA, the MDD was 1412 counts[middle dot]minute-1. In the community, 345 days (87%) were recorded. Three days of monitoring produced acceptable variability estimates of MVPA (R=0.63-0.73). Spearman-Brown prophecy analysis estimated three days would achieve a reliability coefficient of 0.7, and 11 days would achieve 0.9.
Conclusion: Measurement of HPA using the ActiGraph(R) GT3X+ accelerometer is reliable under controlled walking and stepping conditions, as well as in a community environment in independently ambulant children and adolescents with CP.